icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
GefuSHhN6PQdw0KN
Listen
